Table 1 |
||
|
Demographic Data |
||
| BA |
MVD |
|
|
|
||
| Age (years) |
66.1 ± 1.5 |
55.6 ± 1.6 * |
| Gender (%) |
||
| Male |
33(39%) |
37(46%) |
| Female |
51(61%) |
43(54%) |
| ASA Physical Status (%) |
||
| 1 |
8 |
13 |
| 2 |
69 |
67 |
| 3 |
20 |
19 |
| 4 |
2 |
1 |
| Disease Length (Years) |
7.0 ± 0.8 (0.3 – 40) |
5.3 ± 0.7 (0.3 – 32) |
| Number of Medications ** |
||
| 0 |
7 |
1 |
| 1 |
48 |
43 |
| 2 |
36 |
38 |
| 3 or > |
11 |
19 |
| Incidence of Pre-operative Trigger Point Injections (%) |
13.1 |
3.8 * |
| Incidence of prior surgery for TN (%) |
26 |
28 |
|
* P < 0.05 compared to BA All data reported as mean ± SEM, ** Medications use perioperatively include: Carbemazepine, Phenytoin, Baclofen, Neurontin, Depakote) used pre-operatively (%) | ||
Jellish et al. Head & Face Medicine 2008 4:11 doi:10.1186/1746-160X-4-11 |
||
